|
1SM3
CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE
Deposited 1997-12-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain H
2–220(219 aa)
Fragment:FAB FRAGMENT
|
Not recorded
|
CD CADMIUM ION × 8
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;pH 6.0
|
Resolution 1.95 Å
R-free 0.283
|
|
2DLF
HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 6.75
Deposited 1998-12-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
1–115(115 aa)
Fragment:FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.75;CRYSTALLIZATION CONDITIONS: TEMPERATURE AT 20C. PRECIPITANT SOLUTION CONTAINED
1 AMMONIUM SULFATE AND 0.025 M SODIUM CACODYLATE (PH 6.75). 5 MG/ML OF FV
FRAGMENT., VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.55 Å
R-free 0.233
|
|
5A2J
Crystal structure of scFv-SM3 in complex with the naked peptide APDTRP
Deposited 2015-05-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
6–115(110 aa)
Fragment:RESIDUES 6-115,20-129
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.65 Å
R-free 0.197
|
|
5A2K
Crystal structure of scFv-SM3 in complex with APD-TGalNAc-RP
Deposited 2015-05-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
6–115(110 aa)
Fragment:RESIDUES 6-115,20-129
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 6
A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.70 Å
R-free 0.216
|
|
5A2L
Crystal structure of scFv-SM3 in complex with APD-CGalNAc-RP
Deposited 2015-05-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
6–115(110 aa)
Fragment:RESIDUES 6-115,20-129
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 4
A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.79 Å
R-free 0.204
|
|
5N7B
Understanding the singular conformational landscape of the Tn antigens: Sulfur-for- oxygen substitution in the glycosidic linkage provides new insights into molecular recognition by an antibody
Deposited 2017-02-20
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
1–114(114 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 7
A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;20% PEG 3350, 0.2 M disodium hydrogen phosphate
|
Resolution 1.70 Å
R-free 0.211
|
|
5OWP
Crystal structure of glycopeptide "GVTSAfPDT*RPAP" in complex with scFv-SM3
Deposited 2017-09-02
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
6–111(106 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 3
A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;PEG 3350, disodium hydrogen phosphate
|
Resolution 1.85 Å
R-free 0.256
|